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model of hyperglycemia is independent of
myosin isoform
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Martin M LeWinter1,2, Peter VanBuren1,2 and Bradley M Palmer1*Abstract
It has been reported previously that diabetic cardiomyopathy can be inhibited or reverted with chronic zinc
supplementation. In the current study, we hypothesized that total cardiac calcium and zinc content is altered in
early onset diabetes mellitus characterized in part as hyperglycemia (HG) and that exposure of zinc ion (Zn2+) to
isolated cardiomyocytes would enhance contraction-relaxation function in HG more so than in nonHG controls.
To better control for differential cardiac myosin isoform expression as occurs in rodents after β-islet cell necrosis,
hypothyroidism was induced in 16 rats resulting in 100% β-myosin heavy chain expression in the heart. β-Islet cell
necrosis was induced in half of the rats by streptozocin administration. After 6 wks of HG, both HG and nonHG
controls rats demonstrated similar myofilament performance measured as thin filament calcium sensitivity, native
thin filament velocity in the myosin motility assay and contractile velocity and power. Extracellular Zn2+ reduced
cardiomyocyte contractile function in both groups, but enhanced relaxation function significantly in the HG group
compared to controls. Most notably, a reduction in diastolic sarcomere length with increasing pacing frequencies,
i.e., incomplete relaxation, was more pronounced in the HG compared to controls, but was normalized with
extracellular Zn2+ application. This is a novel finding implicating that the detrimental effect of HG on cardiomyocyte
Ca2+ regulation can be amelioration by Zn2+. Among the many post-translational modifications examined, only
phosphorylation of ryanodine receptor (RyR) at S-2808 was significantly higher in HG compared to nonHG. We did
not find in our hypothyroid rats any differentiating effects of HG on myofibrillar protein phosphorylation, lysine
acetylation, O-linked N-acetylglucosamine and advanced glycated end-products, which are often implicated as
complicating factors in cardiac performance due to HG. Our results suggest that the relaxing effects of Zn2+ on
cardiomyocyte function are more pronounced in the HG state due an insulin-dependent effect of enhancing
removal of cytosolic Ca2+ via SERCA2a or NCX or by reducing Ca2+ influx via L-type channel or Ca2+ leak through
the RyR. Investigations into the effects of Zn2+ on these mechanisms are now underway.
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The term diabetic cardiomyopathy refers to a state of
cardiac dysfunction independent of associated coronary
artery disease that arises within weeks of hyperglycemia
(HG) leading to longer term diabetes mellitus (DM) [1].
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reproduction in any medium, provided the orcharacterized in part by elevated end-diastolic left ven-
tricular (LV) pressure, reduced end-diastolic LV vol-
ume, impaired augmentation of LV function in
response to physiological stresses, reduced phospho-
creatine resources and reduced LV filling rates [1-5].
Patients with diabetic cardiomyopathy often experi-
ence exertional dyspnea and a higher incidence of
hospitalization due to heart failure. Currently there
are no proven effective treatments for long term
management of diabetic cardiomyopathy.his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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or type 1 DM induced by treatments targeting pancre-
atic β-islet cells [6,7] are characterized at the cardiomyo-
cyte level by depressed adrenergic responsiveness [8,9],
prolonged action potential duration [10,11], reduced or
delayed calcium influx through sarcolemmal L-type
channels [10], reduced SERCA2a content and calcium
reuptake rate [11,12], greater calcium ion (Ca2+) leak
through the sarcoplasmic reticulum (SR) release chan-
nels also called ryanodine receptors (RyR) [13-15], ele-
vated cytosolic Ca2+ in diastole [15], and reduced
function yet elevated content of mitochondria [16].
These and other findings indicate a broad spectrum of
cellular and molecular mechanisms that underlie the ele-
vated morbidity and mortality associated with diabetic
cardiomyopathy [1,2].
The development of diabetic cardiomyopathy after
6 months of DM in mice is inhibited or reversed by the
chronic administration of zinc [17]. While the cellular
and molecular mechanisms responsible for zinc-induced
protection against diabetic cardiomyopathy are not fully
understood, there is evidence that the zinc-binding pro-
tein metallothionein (MT) plays a role in protection
against oxidative stress associated with diabetic cardio-
myopathy [17-20]. While MT expression may be import-
ant for long term protection against oxidative stress,
zinc also appears protective against oxidative stress in
the short term such as in ischemia-reperfusion injury
[21,22]. How zinc provides MT-independent cardiopro-
tection is not well understood. It is known that extracel-
lular zinc ion (Zn2+) competes with Ca2+ for the
cardiomyocyte L-type calcium channel [23,24]. In
addition, release of SR Zn2+ through the ryanodine
receptors (RyR) also appears to be regulated similarly to
that of SR Ca2+ [25]. Thus, the balance of calcium and
zinc regulation would be a logical focus of inquiry in de-
termining the underling mechanisms responsible for the
protective effects of zinc during the development of dia-
betic cardiomyopathy.
Hypothyroidism accompanies experimental HG and
DM and leads to the upregulation of cardiac β-myosin
heavy chain (MyHC) in rodents [26-29]. The slow β-MyHC
isoform can significantly diminish cardiac contraction-
relaxation function compared to controls, which normally
expressing the faster α-MyHC isoform [5,30-32]. Thus,
this and other secondary effects of HG and DM on
diminished thyroid status must not be erroneously
attributed to primary insulin-dependent effects [26].
In the present study, we hypothesized that extracel-
lular zinc ameliorates cardiomyocyte dysfunction symp-
tomatic of the development of diabetic cardiomyopathy
in rats with HG. To obviate complications of variable
MyHC isoform expression after β-islet necrosis [29],
we induced HG in hypothyroid rats expressing 100%β-MyHC. We found that cardiomyocyte contraction
function was enhanced by HG, but relaxation function
was reduced by HG. Exposure to extracellular Zn2+
reduced contraction function in both HG and nonHG
controls, but enhanced relaxation function only in the
HG. Our findings are consistent with intracellular Ca2+
overload with HG and DM at the cellular level that
can be reduced by exposure to Zn2+.Methods
Rat model
All procedures were reviewed and approved by the In-
stitutional Animal Care and Use Committee of The
University of Vermont College of Medicine and com-
plied with the Guide for the Use and Care of Labora-
tory Animals published by the National Institutes of
Health. Sixteen male Wistar rats (Charles River La-
boratories) were fed an iodine-deficient 0.15% 6-n-pro-
pyl-2-thiouracil (PTU) diet (Harlan Teklan) for at least
12 weeks. After 6 weeks on the diet, eight rats received
tail vein injection of 50 mg/g STZ prepared in sodium
citrate solution. The remaining rats received injection
of similar volume of vehicle. At least 6 weeks after in-
duction of HG by STZ, rats were anesthetized with
1.5-3% inhaled isoflurane, and short-axis view M-mode
echocardiography was performed using Acuson Sequoia
C256 (Seimens Medical Solutions) fitted with a
15 MHz probe suitable for resolving dimensions of the
rat heart. Hearts were removed, and subjects died of
exsanguination. Papillary muscles were then taken for
myofilament performance assessment, apexes were har-
vested for elemental analysis and cardiomyocytes were
isolated from the remaining LV.
Echocardiography
Measures of heart size and function included heart rate,
left ventricular posterior wall thickness (LVPWT), left ven-
tricular diameter at end-diastole (LVD dias) and end-
systole (LVD sys), fractional shortening = (LVD dias - LVD
sys)/LVD dias, ejection fraction = (LVD dias3 - LVD sys3)/
LVD dias3, ejection time taken between QRS complex and
peak shortening, and circumferential velocity = fractional
shortening/ejection time.
Solutions for skinned myocardial strips
Solution concentrations (mmol/L) were formulated by
solving equations describing ionic equilibria [33].
Relaxing solution: pCa 8.0, 5 EGTA, 5 MgATP,
1 Mg2+, 35 phosphocreatine (PCr), 300 U/mL creatine
kinase (CK), ionic strength 200, pH 7.0. Activation
solution: same as relaxing with pCa 4.0. Storage solu-
tion: same as relaxing with 10 μg/mL leupeptin and
50% glycerol wt/vol.
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Skinned myocardial strips were studied as previously
described [34]. Papillary muscles from the LV were
dissected to yield at least two thin strips (~140 μm
diameter, ~800 μm length) with longitudinally oriented
parallel fibers, skinned for 2 hr at 22°C, and stored at
−20°C. Aluminum T-clips were attached to the ends of
a strip ~300 μm apart. The strip was mounted be-
tween a piezoelectric motor (Physik Instrumente, Au-
burn, MA) and a strain gauge (SensorNor, Horten,
Norway), lowered into a 30 μL droplet of relaxing so-
lution (pCa 8.0) maintained at 37°C, and incrementally
stretched to 2.2 μm sarcomere length measured by
digital Fourier Transform (IonOptix Corp, Milton,
MA). Strips were calcium activated from pCa 8.0 to
pCa 4.8.
Recorded forces were normalized to cross-sectional
area to provide isometric tension (T). Individual
recordings of T minus relaxed tension (Tmin) were then
normalized to maximum developed tension (Tmax–Tmin)
and fit to the Hill equation:
T Tminð Þ= Tmax–Tminð Þ
¼ Ca2þ n= Ca2þ 50
n þ Ca2þ n
 
; ð1Þ
where [Ca2+]50 = calcium concentration at half activa-
tion, pCa50 = −log [Ca
2+]50, and n = Hill coefficient using
a nonlinear least squares algorithm (Sigma Plot 8.0, SPSS,
Chicago, IL).
Tension-velocity relationship
The force-clamp technique was applied at maximal calcium
activation. Various mechanical loads were expressed as a
fraction of maximum absolute tension (Tmax). Force was
maintained constant over a designated period of time
using software-based feedback control, and the length
change was continuously monitored. The tension-
velocity (T-V) relationship was generated from these
data.
The relationship was fit to a hyperbolic Hill equation
normalized to Tmax:
T0 þ a0ð Þ V þ bð Þ ¼ 1þ a0ð Þb; ð2Þ
where T'= T/Tmax, a'= a/Tmax, and a and b are the
parameters of the non-normalized hyperbolic Hill
equation using a nonlinear least squares algorithm
(Sigma Plot 8.0, SPSS, Chicago, IL). The physiological
characteristics maximum unloaded shortening velocity
(Vmax), velocity at maximum power (Vopt), tension at
maximum power (T`opt) and maximum powerproduction (Pmax) were calculated from a' and b, as follows
[31,32]:
Vmax ¼ b=a0 ML=sð Þ
Vopt ¼ b 1þ 1=a0ð Þ1=2– a0 ML=sð Þ
T0opt ¼ a02 þ a0ð Þ1=2– a0 fraction of Tmaxð Þ





fraction of Tmax:ML=sð Þ;
ð3Þ
Native thin filament isolation
Intact native thin filaments were isolated from ventricu-
lar tissue as described previously [35]. In brief, myofibrils
were isolated from flash frozen muscle tissue and subse-
quently homogenized in the following solution (in
mmol/L): 100 NaCl, 5 MgCl2, 1 NaN3, 1 ethylene glycol
tetraacetic acid (EGTA), 5 MgATP, 10 Na3PO4 and 2 μg/
ml leupeptin at a ratio 40 ml/gm of myofibril (pH 6.5).
Debris and thick filament were pelleted with centrifuga-
tion 137,000 × g for 20 minutes. Native thin filaments
were then collected with centrifugation (137,000 x g for
180 minutes) with the pellet being raised in low salt
buffer (in mmol/L): 25 KCl, 25 imidazole, 1 EGTA, 5
MgCl2, 10 DTT. Protein concentration was determined
for native thin filaments with a protein assay (Bio-Rad;
Hercules, CA, USA) using bovine serum albumin as the
standard. Chicken skeletal myosin was isolated as previ-
ously described. Chicken skeletal myosin was used as
the motility substrate in the in vitro motility assay due
to its temporal stability, creating consistency between
experiments [35]. Native thin filaments were labeled
with rhodamine-phalloidin (1:1 molar ratio) prior to use
in the motility assay.
In vitro motility assay
Native thin filament contractile performance was
assessed using the in vitro motility as described previ-
ously [36]. In brief, myosin (100 μg/ml, unless otherwise
noted) was applied for one minute to a nitrocellulose
coated coverslip in a high salt buffer (in mmol/L): 300
KCl, 25 imidazole, 5 MgCl2, 2 EGTA and 10 DTT. The
surface was then washed with bovine serum albumin
(0.5 mg/ml) in low salt buffer. Employing epifluorescent
microscopy, rhodamine-labeled thin filaments were
observed moving across the myosin coated surface in
the presence of MgATP (2 mmol/L) in a buffered motil-
ity solution (in mmol/L unless otherwise noted): 25 KCl,
25 imidazole, 5 MgCl2, 2 EGTA and 10 DTT, glucose
oxidase 0.1 mg/ml, catalase 1.8 μg/ml, glucose 2.3 mg/
ml, and 0.38% methylcellulose. Free calcium was varied
in the motility solution (pCa 10–4.0). Thin filament mo-
tility was recorded on videotape, and subsequently ana-
lyzed with the motion analysis system VP110 (Motion
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individual filament velocities were averaged to determine
the mean velocity of each experiment. All motility
experiments were performed at 30°C.
Isolated cardiomyocyte function
Rat LV cardiomyocytes were isolated using retrograde
perfusion of collagenase solution according to methods
described elsewhere [37]. Cardiomyocytes were observed
with a 40× objective on an inverted microscope (Nikon
Diaphot) while bathed in normal Tyrode’s solution con-
taining in mmol/L: 137 NaCl, 5.4 KCl, 1.2 CaCl2, 0.5
MgCl2, 10 HEPES, 5.5 glucose, 0.5 probenecid at 37°C
(pH 7.4). Cardiomyocytes were electrically paced at 2, 4
and 6 Hz for at least 5 minutes at each frequency. Half
of the cardiomyocytes were exposed to Tyrode’s with
32 μM Zn-acetate. Dynamic sarcomere length was
detected by Fourier Transform of the digital image.
A subset of cardiomyocytes from each heart was
loaded with Fura-2 AM (Invitrogen, Carlsbad, CA) and
excited at 365 nm and 400 nm. Emission at 510 nm was
used to detect Fura-2 fluorescence at each pacing fre-
quency, although not with zinc exposure. We did not
measure intracellular Ca2+ during Zn2+ exposure, be-
cause Fura-2 is sensitive to both physiological Zn2+ and
Ca2+ [23] and we would not have been able to differenti-
ate the two ions. Background fluorescence was detected
after lysing cardiomyocytes with 4 μM digitonin. Para-
meters of fluorescence ratio 365/400 (R) dynamics were
used to represent those of calcium dynamics [38].
Myosin isoform determination and western blots
Ventricular myosin isoform content of HG and nonHG
rats was determined by the method of Reiser and
Kline [39] with the use of Fluormax-2 Imaging analysis
(Bio-Rad, Hercules, CA). Protein phosphorylation stain
(Pro-Q diamond, Invitrogen) and Western blots for
myosin regulatory light chain (MLC2) content (cat.
ab92721, Abcam, San Francisco, CA), MLC2 phosphor-
ylation (MLC2-P) at Serine-19 (cat. ab2480, Abcam),
RyR (cat. MA3-916, Thermo Scientific), RYR phosphoryl-
ation at Serine-2808/9 (cat. A010-30AP, Badrilla), O-
linked N-Acetylglucosamine (cat. ab2739, Abcam), lysine
acetylation (cat. #9441, Cell Signaling Technologies) and
pentosidine (PEN012, Biologo) were performed using tis-
sue homogenates prepared in (mmol/L) 300 KCl, 25
Imidazole, 5 MgCl2, 2 EGTA, 10 DTT and pH 7.4. In
some cases, myofilament fraction was extracted as the
pellet after centrifugation and non-myofilament fraction
as the supernatant.
Cardiac element content measurements
Polypropylene conical tubes of 15 mL volume were
soaked in 0.4 mM EGTA overnight, then rinsed fourtimes with ddH2O and allowed to drip dry according to
published recommendations [40]. Between 40–80 mg of
each LV sample was placed in its own tube and lyophi-
lized by 90 min of vacuum freeze drying. Samples were
digested in 10 μL nitric acid (15.8 Normal) per mg tissue
wet weight. Gallium was added in the amount 0.2 μL of
1 g/L Ga standard per mg tissue wet weight. Finally,
ddH2O was added to bring total volume to 200× dilu-
tion of original tissue wet weight including final concen-
trations of 0.8 N nitric acid and 1 ppm Ga. Standards
were prepared for elements Ca, Cu, Fe, K, Mg, Na, P, S
and Zn over ranges 0–0.4 ppm, 0–4 ppm or 0–40 ppm
depending on the element and all including 0.8 N nitric
acid and 1 ppm Ga. Detection of element content was
performed using inductively coupled plasma atomic
emission spectroscopy (ICP-AES) performed by the
ULTIMA2C operated in Poly-mode (Horiba Scientific,
Edison, NJ). Element content was detected in triplicate
for each sample and normalized against the Ga internal
standard to provide a measure of element content in
ppm relative to tissue wet weight.
mRNA analysis and quantitative PCR
Total RNA was extracted from the rat hearts using
Qiagen RNeasy kit and cDNA was synthesized using
Invitrogen Superscript III first-strand synthesis system
according to manufacturer instructions. Taqman primer
sets were purchased from Applied Biosystems (Life
Technologies): reference numbers HPRT Rn01527840,
MT1a Rn00821759, ZnT2 Rn00563633 and γ-GCSh
Rn00689046. Cycle threshold (Ct) values from quantita-
tive RT-PCR were obtained from ABI Prism 7900HT
sequence detection system. The mRNA expression levels
measured as Ct were normalized to that of the endogen-
ous control, HPRT, as ΔCt. The average ΔCt of the
nonHG controls was used as the normalization factor to
determine ΔΔCt for the HG group. Relative fold differ-
ence (RQ) in transcription levels between the HG and
nonHG groups was calculated as RQ = 2-ΔΔCt.
Statistical analysis
Analysis was performed using PASW Statistics 18.0
(SPSS). Multiple measurements of myofilament perform-
ance from the same heart were averaged to provide a
single measure for that heart. Tension and actin velocity
were normalized to values at maximal calcium activation
and fit to the Hill equation using a non-linear least
squares algorithm (Sigma Plot 8.0, SPSS, Chicago, IL).
Repeated-measures ANOVA, using stimulation fre-
quency within the same cardiomyocyte and zinc expos-
ure within the same heart as repeated measures, was
used to detect the relative effects of frequency and zinc
exposure between HG and nonHG controls. Data are
presented as mean ± SEM. For function analyses, n = 8
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reported at the P<0.05, P<0.01 and P<0.001 levels.
Trends at P<0.1 are also reported if in support of other
statistically significant results.Results
Animal characteristics
STZ induced a dramatic rise in serum glucose concen-
tration in the HG rats, indicative of depressed insulin
production by the pancreas (Table 1). Other notable
consequences of 6 wks of HG included a reduction in
body weight. There were no other highly significant
effects of HG in the context of hypothyroidism on car-
diac dimension or performance as measured by echocar-
diography. There was a trend (P<0.10) for a prolonged
ejection time with HG, which reflects a prolonged acti-
vation of the force-producing myofilaments at the end of
systole.Myofilament performance
Hypothyroidism inhibited the expression of α-MyHC
and resulted in 100% β-MyHC incorporation into both
HG and nonHG rats as shown in Figure 1A. In euthyr-
oid rats, a similar bout of HG due to STZ resulted in a
shift of the myosin isoform profile from a ~85/15 ratio
of α-MyHC/β-MyHC in the nonHG to ~50/50 ratio in
the HG (Figure 1A). Unless specified, we examined the
hypothyroid rats and thus eliminated the complications
of different myosin isoform mixtures [29]. Phosphoryl-
ation of myofibrillar proteins and specifically MLC2
were similar between HG and nonHG control rats
(Figure 1B-1D).Table 1 Rat model characteristics, echo morphometry
and serum glucose
HG (n=8) nonHG (8)
Age (wks) 19.8 ± 0.3 20.1 ± 0.4
PTU diet (wks) 12.8 ± 0.3 13.1 ± 0.4
Body mass (g) 217 ± 5 † 278 ± 15
Glucose 1 wks (mg/dL) 287 ± 20 no measure
Glucose 6 wks (mg/dL) 422 ± 21 †† 75 ± 6
Heart rate (bpm) 213.3 ± 9.1 229.1 ± 5.0
LVD dias (mm) 6.99 ± 0.18 6.88 ± 0.26
LVD sys (mm) 4.40 ± 0.16 4.41 ± 0.25
Fractional Shortening (%) 37.0 ± 1.7 35.9 ± 2.3
Ejection Fraction (%) 74.7 ± 1.9 73.0 ± 2.7
Ejection Time (ms) 146.6 ± 5.6 # 135.8 ± 2.7
Circum. Velocity (circ/s) 2.56 ± 0.17 2.67 ± 0.21
LVPWT dias (mm) 1.35 ± 0.09 1.23 ± 0.09
Statistical differences by two-tailed t-test between HG and nonHG. #P<0.10,
†P<0.01, ††P<0.001.Myofilament calcium sensitivity
Minimum tension, maximal tension and calcium-
activated developed tension of skinned myocardial strips
were not different between HG and nonHG controls
(Table 2). Calcium sensitivity of developed tension,
visualized as the normalized tension-calcium relation-
ships in Figure 2A, were indistinguishable between the
HG and nonHG strips at all pCa conditions. The sensi-
tivity of the thin filament to calcium activation, indicated
by pCa50, and the cooperativity coefficient, nHill, were
also unchanged by HG (Table 2).
The velocity-calcium relationships of the native thin
filaments (NTF) isolated from the HG and nonHG con-
trol rats were indistinguishable from each other
(Figure 2B). Parameters for maximal NTF calcium-
activated velocity and calcium sensitivity of NTF were
also similar in HG and nonHG (Table 2). Moreover,
NTF function was not affected by STZ treatment in eu-
thyroid rats (Figure 2B, inset). These results for tension-
calcium and NTF velocity-calcium relationships indicate
that thin filament function was not affected by 6 wks of
HG in hypothyroid or euthyroid rats.
Tension-velocity relationship
Examples of clamped force and corresponding length
changes, which illustrate the force-clamp technique, are
shown in Figures 3A and 3B. Velocity was calculated over
40–60 ms after force-clamp was initiated, which allowed
for steady force maintenance and was always within 5%
of the originally set sarcomere length. Tension-velocity
and tension-power relationships recorded from force-
clamp experiments are shown in Figures 3C and 3D. We
found no differences in the velocity- and power-tension
relationships between HG and nonHG controls. Para-
meters of the maximum velocity, optimum velocity,
optimum tension and maximum normalized power pro-
duction, which are indicators of myofilament contractile
performance, were also not different between HG and
nonHG controls (P>0.10, Table 3).
Cardiomyocyte sarcomere dynamics
Representative cardiomyocyte sarcomere dynamics are
illustrated in Figures 4A-D. Cardiomyocyte sarcomere
shortening at 2 Hz (Figure 4A and 4B) was greater in
the HG (6.46 ± 0.28%) compared to nonHG controls
(5.48 ± 0.28%, P<0.05), but not at 6 Hz (Figures 4C and
4D). Diastolic sarcomere length at all pacing frequencies
was shorter in the HG (1.736 ± 0.010 μm at 2 Hz) com-
pared to nonHG controls (1.770 ± 0.007 μm at 2 Hz,
P<0.05). In both groups, diastolic sarcomere length shor-
tened as pacing frequency increased, i.e., there was a
lack of full relaxation with increasing pacing frequency.
The HG group displayed a greater lack of full relaxation


















MW   Myosin    Tn   
MyBP-C
Tm
HG nonHG  HG nonHG
Coomassie -Blue Phospho-stain 








HG        nonHG
Hypothyroid Euthyroid
Figure 1 Myosin isoforms and myofibrillar protein phosphorylation. A. Gel electrophoresis stained with Coomassie-Blue demonstrate 100%
β-MyHC content in both HG and nonHG groups due to hypothyroidism. In euthyroid rats, HG results in a significant upregulation of cardiac
β-MyHC compared to the α-MyHC predominately expressed in the nonHG rat heart. B and C. Coomassie-blue and phospho-stain by Pro-Q
Diamond indicated similar phosphorylation profiles of myofibrillar proteins in HG and nonHG. D. Western blots of phosphorylated MLC2 (MLC2-P)
and total MLC content demonstrated similar degrees of phosphorylation in HG and nonHG controls. Additional lanes indicating alkaline
phosphatase (AP) treatment to dephosphorylate MLC2 and myosin light chain kinase (MLCK) treatment to phosphorylate MLC2 provided
negative and positive controls for MLC2 phosphorylation. Myosin = chicken skeletal myosin standard, Tn = bovine cardiac troponin standard,
MyBP-C = myosin binding protein-C, Tm = tropomyosin, LC = myosin light chain.
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shortening in both HG and nonHG. Extracellular Zn2+
enhanced diastolic sarcomere length significantly in the
HG, particularly as pacing frequency increased, but did
not significantly affect diastolic sarcomere length in
the nonHG. Quantitative analyses regarding thesensitivity of contraction-relaxation function to HG,
pacing frequency and Zn2+ are presented below.
Contraction function
The variables used here to represent cardiomyocyte con-
tractile function were peak sarcomere shortening and
Table 2 Characteristics of myofilament force production
in the skinned strip and of native thin filament (NTF)
velocity in the myosin motility assay
HG (n=6) nonHG (6)
Tmin (mN/mm
2) 4.24 ± 0.33 4.87 ± 0.18
Tmax (mN/mm
2) 15.8 ± 1.4 16.9 ± 1.7
Tdev (mN/mm
2) 11.6 ± 1.6 12.1 ± 1.8
pCa50 5.88 ± 0.02 5.89 ± 0.02
nHill 3.41 ± 0.38 3.06 ± 0.16
(n=3) (3)
VCa, NTF (µm/s) 4.52 ± 0.30 4.62 ± 0.29
pCa50, NTF 6.35 ± 0.07 6.32 ± 0.06
nHill, NTF 1.36 ± 0.22 1.39 ± 0.23
Tmin= minimum tensile stress, Tdev = developed tensile stress, pCa50 = pCa at
50% calcium activation, nHill = Hill coefficient, VCa, NTF = calcium-dependent
NTF velocity.
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cardiomyocyte peak shortening and maximum shorten-
ing velocity were statistically enhanced in HG compared
to nonHG at 2 and 4 Hz pacing frequency, but not at
6 Hz (Figure 5A). Contractile function was reduced with
increasing pacing frequency indicated by significant
‘freq’ main effects (P<0.001 in Table 4). There were also
significant ‘HG×freq’ interactions for peak shortening
and maximum shortening velocity (P<0.01 in Table 4)
suggesting that the HG group was more susceptible to
the reduction in contractile function with increasing
pacing frequency. Exposure to extracellular Zn2+
reduced peak shortening and maximum shortening
velocity (note significant ‘zinc main effect’ P<0.001 for
these variables in Table 4) in both groups andA
HG
nonHG
Figure 2 Thin filament characteristics and myofilament performance.
nonHG controls were not different from each other, indicating similar thin
velocity-calcium relationships detected using the myosin motility assay we
sensitivity and myosin-actin MgATPase activity. Inset illustrates that HG didsubdued any differences between HG and nonHG
controls (Figure 5A).
Relaxation function
The variables used here to represent cardiomyocyte re-
laxation function were maximum relengthening velocity,
times to 50% relengthening, and diastolic sarcomere
length. Without Zn2+ exposure, maximum relengthening
velocity was significantly enhanced in the HG at 2 and
4 Hz, but not at 6 Hz (Figure 5C). Maximum relength-
ening velocity was consistently enhanced with pacing
frequency in the nonHG controls (Figure 5C), but not as
much in the HG group (note significant freq main effect
P<0.001 and HG×freq interaction P=0.011 in Table 5).
These latter results indicate a reduced relaxation-
frequency response due to HG. During Zn2+ exposure,
maximum relengthening velocity remained significantly
enhanced in the HG group compared to nonHG con-
trols at 2 and 4 Hz (Figure 5C).
Time to 50% relengthening (Figure 5D) was not dif-
ferent between HG and nonHG unless cardiomyocytes
were exposed to Zn2+. Specifically, during Zn2+ expos-
ure, time to 50% relaxation was significantly shorter in
the HG compared to nonHG at 2 and 4 Hz, but not
6 Hz (Figure 5D). A similar effect, although not statis-
tically significant (P<0.15), was observed for time to
10% relengthening (not shown) and time to peak
(Figure 5B).
Diastolic sarcomere length was significantly shorter in
the HG compared to nonHG at all pacing frequencies
both without and during Zn2+ exposure (Figure 5E). Dia-
stolic sarcomere length shortened with increasing pacing






A. Normalized isometric tension-calcium relationships of HG and
filament sensitivities to calcium activation. B. Native thin filament (NTF)
re also similar between HG and nonHG demonstrating similar calcium








Figure 3 Example of force-clamp technique and results of tension-velocity and tension-power relationships. A. The force clamp
technique relies upon using the force signal as feedback to the muscle length so that a preset force is achieved. The preset force varies from
10-96% and several examples are shown here. B. The resulting length change indicates velocity of contraction at the preset force. Velocity was
calculated between 40–60 ms after the change in load. C-D. Tension-velocity and tension-power relationships were similar in HG and nonHG
controls.
Table 3 Characteristics of force-velocity relationships in
skinned strips
HG (n=6) nonHG (6)
a/Tmax (no units) 0.501 ± 0.086 0.392 ± 0.102
b (10-3 ML/s) 414 ± 104 347 ± 95
Vmax (10
-3 ML/s) 817 ± 125 899 ± 85
Vopt (10
-3 ML/s) 292 ± 45 291 ± 35
Topt/Tmax (%) 35.8 ± 1.5 32.5 ± 2.8
Pmax (10
-3 ML/s × T/Tmax) 106 ± 18 98 ± 17
a/Tmax = curvature index, b = velocity index, Vmax = extrapolated maximum
unloaded velocity, Vopt = velocity at maximum power, Topt/Tmax = relative
tension at maximum power, Pmax = maximum normalized power.
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http://www.cardiab.com/content/11/1/135effect P<0.001 in Table 4), but significantly more so in
the HG compared to nonHG (indicated by HG×freq
interaction P=0.005 in Table 4).
As noted in Figure 5E, the reduction in diastolic
sarcomere length with pacing frequency in the HG
group appeared more subtle during Zn2+ exposure. In-
deed, there was a HG×freq×zinc interaction P=0.037 for
diastolic sarcomere length, which indicated a different
sensitivity to pacing frequency between the groups that
was dependent upon Zn2+ exposure. This interaction
can be visualized more easily in Figure 5F, where the
change in diastolic sarcomere length from that at 2 Hz
is illustrated. As seen in Figure 5F, diastolic sarcomere
length was reduced with increasing pacing frequency in













Figure 4 Representative cardiomyocyte sarcomere shortening-relengthening transients with (−−-) and without (—) 32 μM extracellular
Zn2+ and intracellular Ca2+ transients. A and B. At 2 Hz cardiomyocyte shortening was greater in HG compared to nonHG. Diastolic sarcomere
length was noticeably shorter in HG compared to nonHG at 2 Hz. Extracellular Zn2+ reduced cardiomyocyte shortening in both HG and nonHG
and led to longer diastolic sarcomere lengths in HG. C and D. At 6 Hz extracellular Zn2+ reduced cardiomyocyte shortening in both HG and
nonHG. Diastolic sarcomere length was still noticeably shorter in HG compared to nonHG, and exposure to Zn2+ led to longer diastolic
sarcomere lengths in the HG group. E and F. At 2 and 6 Hz, fluorescence ratio transients of HG and nonHG cardiomyocytes were similar in
temporal characteristics, but there was a greater area under Fura-2 fluorescence ratio transient in the HG at 2 Hz and a trend at 6 Hz.
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http://www.cardiab.com/content/11/1/135without Zn2+. The diastolic sarcomere length in the HG
cardiomyocytes exposed to Zn2+ responded to pacing
frequency similar to the nonHG group (Figure 5F).
In summary, relaxation function measured as max-
imum relengthening velocity, time to 50% relength-
ening and diastolic sarcomere length in the HG
cardiomyocytes was more sensitive to the enhancing
effects of extracellular Zn2+ compared to that in
nonHG controls.Cardiomyocyte calcium dynamics
Figures 4E and 4 F illustrate representative fluorescence
ratio transients that reflect calcium dynamics in the car-
diomyocytes of the HG and nonHG groups not exposed
to Zn2+. Indices of systolic and diastolic performance are
presented in Figure 6. The developed peak fluorescence
ratio (R), i.e., peak minus diastolic R (Figure 6A), was
not statistically different between HG and nonHG, al-


















Figure 5 Parameters of cardiomyocyte sarcomere dynamics. A. Peak cardiomyocyte shortening was greater in HG compared to nonHG at
2 and 4 Hz, but not at 6 Hz. Exposure to 32 μM [Zn2+]ex reduced peak shortening in both groups and abolished differences in peak shortening
between the groups. B. Time to peak shortening was not different between HG and nonHG and not affected by zinc exposure. C. Both with and
without [Zn2+]ex, maximum velocity of relengthening was greater in HG compared to nonHG at 2 and 4 Hz, but not at 6 Hz. Maximum velocity of
relengthening in the nonHG group was enhanced with pacing frequency, but not as much in the HG group. D. Time to 50% relengthening was
enhanced by 32 μM [Zn2+]ex in the HG group only. E. Diastolic sarcomere length was shorter in HG compared to nonHG and shortened in both
groups by increasing pacing frequency. F. The change in diastolic sarcomere length with pacing frequency was greatest in HG cardiomyocytes
not exposed to [Zn2+]ex. Exposure to 32 μM [Zn2+]ex in the HG cardiomyocytes recovered a normal response of diastolic sarcomere length to
pacing frequency. #P<0.1, *P<0.05, †P<0.01; n=8 in each group.
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R decay, time to 50% R decay and diastolic R were not
different between HG and nonHG at any pacing fre-
quency (Figures 6B-6E). Contrary to the higher SER-
CA2a expression and SR Ca2+ reuptake rate reported for
rats with type 2 DM [41], we did not detect a greater SR
Ca2+ reuptake rate in the HG cardiomyocytes. However,
the area under the R transient, not including the area
under diastolic R, was greater in the HG compared to
nonHG at all pacing frequencies (Figure 6F and Table 5).These data would suggest that there was greater total
cytosolic calcium over each cardiac cycle in the HG
compared to nonHG in the absence of Zn2+ exposure. A
greater total cytosolic calcium in the HG could explain
in part the enhanced contraction function in the HG at
the 2 Hz and 4 Hz pacing frequencies.
Other post-translational modifications
We examined several post-translational modifications
implicated as significant modifiers of cardiomyocyte
Table 4 Results of repeated measures ANOVA of cardiomyocyte shortening-relengthening characteristics
Variable HG freq HG×freq zinc HG×zinc freq×zinc HG×freq×zinc
Peak Shortening (%) 0.013* <0.001† 0.008† <0.001† 0.941 0.619 0.424
Peak Shortening (μm) 0.043* <0.001† 0.008† <0.001† 0.992 0.698 0.374
Max Shortening dSL/dt (μm/s) 0.028* <0.001† 0.016* <0.001† 0.922 0.624 0.582
Max Lengthening dSL/dt (μm/s) 0.002* <0.001† 0.011* <0.001† 0.833 0.121 0.827
Time to Peak (ms) 0.712 <0.001† 0.295 0.354 0.158 0.153 0.674
Time to 10% return (ms) 0.505 <0.001† 0.082# 0.294 0.215 0.094# 0.706
Time to 50% return (ms) 0.230 <0.001† <0.001† 0.554 0.249 0.368 0.534
Diastolic SL (μm) <0.001† <0.001† 0.005† 0.722 0.913 0.176 0.037*
The table presents P-values for the main effects of HG, freq and zinc and for interactions of HG×freq, HG×zinc, freq×zinc and HG×freq×zinc. #P<0.10, *P<0.05,
†P<0.01; n=8 in each group.
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2808 was enhanced in HG compared to nonHG
(Figures 7A and 7B) as has been reported previously and
implicated as a contributor of increased SR Ca2+ leak in
HG [15]. The elevated phosphorylation of RyR S-2808
may result from a moderately elevated adrenergic envir-
onment in the myocardium due to reduced reuptake of
norepinephrine in sympathetic nerves [42].
O-linked N-Acetylglucosamine (O-GlcNAc), which is
known to occur with complications in HG and DM [43],
was highly variable in both HG and nonHG samples, but
was not detected on the major myofilament proteins
(Figure 7C). The protein most subject to O-GlcNAc had
a molecular weight of ~65 kDa, possibly one of the
intermediate filament proteins synocoilin or desmin, but
was not differently affected in HG and nonHG controls
(Figure 7C).
Accumulation of advanced glycated end-products
(AGE), implicated as a contributor to myocardial stiff-
ness in HG [44], was detected using anti-pentosidine
probe (Figure 8B). Neither the myofilament nor non-
myofilament fractions of the tissue homogenate demon-
strated differential AGE accumulation due to HG.
Lysine acetylation, which has been implicated as a sig-
nificant modifier of myosin and myofilament function
[45], was not apparent in myosin or in any of the major
myofilament proteins (Figure 8A). Our examination ofTable 5 Results of repeated measures ANOVA of
cardiomyocyte calcium transient characteristics
Variable HG freq HG×freq
Peak – Diastolic Ratio (R) 0.107 0.250 0.828
Area of Ratio Transient (R.ms) 0.079# <0.001† 0.179
Time to Peak (ms) 0.673 <0.001† 0.941
Time to 50% return (ms) 0.111 <0.001† 0.546
Exponential Time Constant (ms) 0.514 <0.001† 0.815
Diastolic Ratio (R) 0.340 0.100 0.532
The table presents P-values for the main effects of HG and freq and for
interactions of HG×freq. #P<0.10, *P<0.05, †P<0.01; n=8 in each group.myofilament composition in terms of myosin isoform
and of commonly assessed post-translational modifica-
tions of myofilament proteins did not result in our find-
ing any significant differences between the HG and
nonHG hypothyroid rats.
Cardiac element content
HG in the hypothyroid rat led to elevations in iron and
sulfur per cardiac tissue wet weight (Table 6), while
there was no effect on the other elements. In particular,
myocardial calcium and zinc concentrations were similar
between the HG and nonHG hypothyroid rats. Euthryr-
oid rats, however, responded to HG with an elevation in
calcium, potassium, sodium and sulfur and a reduction
in copper and iron (Table 6). Interestingly, neither the
hypothyroid nor euthyroid rats demonstrated changes in
magnesium, phosphorus or zinc content due to HG, and
both hypothryroid and euthyroid rats demonstrated a
~20-25% increase in sulfur with HG.
Gene expression
Zinc binds to the metal responsive element (MRE) on
the promoter region of select genes and thereby signals
activity of metal response element-binding transcription
factor-1 (MTF-1) and the subsequent transcription of
several genes related to zinc homeostasis and protection
against oxidative stress: metallothionein-1 (MT1a), γ-
glutamylcysteine synthase heavy chain (γ-GCSh) and
zinc transporters-1 and -2 (ZnT1, ZnT2) [46-48]. Given
the previous findings of an upregulation of MT1a in
mouse hearts after STZ injection [19], we expected a
similar upregulation of MTF-1 dependent genes in the
hearts of our euthyroid HG rats. (We did not examine
gene expression in the hypothyroid rats due to lack of
tissue.) Instead we found that HG due to STZ injection
led to a significant reduction in MT1a and ZnT2 expres-
sion, similar to a downregulation of MT1a in cardiac tis-
sue of diabetic mouse embryos [49] (Table 6). Our data
suggest that MTF-1 activity is reduced with HG,











Figure 6 Parameters of cardiomyocyte calcium dynamics. A. Peak fluorescence ratio was not different between HG and nonHG, except at
6 Hz where there was a trend for higher peak ratio in HG. B-E. Time to peak fluorescence ratio, exponential decay time constant, time to 50%
decay in fluorescence ratio and diastolic fluorescence ratio were not different between HG and nonHG. F. Area under the fluorescence ratio
transient was higher in HG compared to nonHG at 2 Hz and demonstrated similar trend at 4 and 6 Hz. #P<0.1, *P<0.05; n=8 in each group.
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http://www.cardiab.com/content/11/1/135normal level of Zn content. We also report an upregula-
tion of γ-GCSh, which is consistent with the increased
glutathione content in the hearts of diabetic mouse
embryos [49]. The regulation of γ-GCSh in this case is
likely driven by some other transcription factor other
than MTF-1 [50], due in part to the promoter of the
γ-GCSh gene bearing only a single MRE and may not
be as dependent upon MTF-1 activity as MT and ZnT
genes bearing 3–6 MRE’s [50].
Discussion
We report here the effects of HG induced by β-islet ne-
crosis on cardiomyocyte function in hypothyroid rats.
Hypothyroidism was induced in these rats to ensure the
expression of 100% β-MyHC in the ventricles of bothdisease and control groups. We found no significant
effects of HG on echocardiographic measures of cardiac
function or on myofilament performance in the context
of hypothyroidism. These findings support the argu-
ments raised by Dillmann [27], Davidoff et al. [5,26] and
Rundell et al. [29] that modifications in myofilament
function due to HG in rodents are primarily if not exclu-
sively through myosin isoform shifts secondary to asso-
ciated hypothyroidism. With our unique animal model
of HG, we were able to demonstrate the effects of HG
on cardiomyocyte function independent of differential
MyHC isoform expression and its associated effects on
myofilament performance and yet with greater relevance
to the human heart, which expresses predominately
β-MyHC.




HG nonHG  HG nonHG









RyR S-2808-P total RyR
B *
HG                nonHG
Figure 7 Post translational modifications due to HG. A and B. RyR phosphorylation at S-2808 normalized to total RyR content was
significantly enhanced in HG compared to nonHG. C. O-linked N-Acetylglucosamine (O-GlcNAc) was not apparent in myofibrillar proteins except
possibly an interfilament protein at ~65 kDa, which was not differentially affected by HG. MW = molecular weight marker. *P<0.05; n=4.
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We found that extracellular Zn2+ enhanced relaxation
function only in the cardiomyocytes of HG rats and
not in the nonHG. Most notably, incomplete relax-
ation as pacing frequency increased was more promin-
ent in HG, and extracellular Zn2+ exposure to the HG
cardiomyocytes regained a normal relaxation response
to pacing frequency. This is a novel and important
finding that highlights the detrimental effect of HG on
cardiomyocyte Ca2+ regulation and its amelioration by
Zn2+. These results are consistent with the idea that
HG leads to a higher cardiomyocyte intracellular Ca2+
load leading to incomplete relaxation and also a
higher sensitivity to the relaxing effects of extracellular
Zn2+.
The molecular mechanisms, which underlie cardio-
myocyte relaxation affected by extracellular Zn2+ ex-
posure or intracellular Zn2+ accumulation, may be
targets for the treatment of diastolic dysfunction in
diabetic cardiomyopathy. Due to the protean effects of
zinc on cellular functions an exhaustive study of zincs
effects on cardiomyocyte contractile function is beyond
the scope of our current investigation. IntracellularZn2+ is known to activate or deactivate a number of
kinases and phosphatases, reviewed in Foster and Sam-
man [51], as well as compete with Ca2+ for calcium
regulatory proteins and channels [23,24]. Given the
rapidity with which the extracellular Zn2+ exposure
affected cardiomyocyte function and the recent findings
that Zn2+ regulation appears to follow that of Ca2+ [25],
we would hypothesize that the most immediate effects of
Zn2+ on cardiomyocyte function involve a competitive ef-
fect on Ca2+ regulatory mechanisms. By reducing the in-
ward Ca2+ current through the L-type channel [23,24],
for example, extracellular Zn2+ exposure could lower
the open probability of RyR and presumably also re-
duce SR Ca2+ leak through the RyR, which has been
shown to be elevated in HG [13,14]. Our finding an
elevated RyR phosphorylation at S-2808 in our HG
rats is consistent with that reported by others [15]
and suggests that the hypothyroid state did not di-
minish the effects of HG on RyR post-translational
modifications and possibly also its function. It must
be noted, however, that HG-dependent enhancement
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Figure 8 Post translational modifications due to HG. Myofilament (pellet) and non-myofilament (supernatant) proteins were separated by
centrifugation of tissue homogenate. A. Lysine acetylation was not detected for any myofibrillar protein except two unidentified proteins at
<20 kDa. These were not differentially acetylated between HG and nonHG. B. Advanced glycation end-products (AGEs), detected by Western
blots of anti-pentosidine probe, demonstrated similarly low AGEs accumulation in myofilament fraction between HG and nonHG. AGEs
accumulation of non-myofilament proteins appeared in two proteins at ~27 kDa and ~55 kDa, but was highly variable and not different
between HG and nonHG.
Table 6 Cardiac element content and select gene
expression at 6 wks after injection of STZ (HG) or vehicle
(nonHG) in hypothyroid rats fed PTU diet or in euthyroid
rats fed standard rat chow
Hypothyroid Euthyroid
HG (n=8) nonHG (8) HG (6) nonHG (6)
Ca 101.2 ± 6.0 100.8 ± 7.4 284.4 ± 44.3* 155.4 ± 32.9
Cu 4.4 ± 0.2 3.9 ± 0.2 5.2 ± 0.3 * 6.4 ± 0.2
Fe 66.7 ± 3.0* 58.7 ± 1.9 95.5 ± 2.5 † 122.3 ± 7.5
K 2316 ± 148 2053 ± 85 7369 ± 793 * 5052 ± 566
Mg 186.8 ± 8.9 177.3 ± 7.6 275.1 ± 13.6 257.8 ± 6.0
Na 1863 ± 102 1788 ± 75 2325 ± 224 * 1641 ± 186
P 2158 ± 105 2012 ± 81 2726 ± 86 2711 ± 24
S 2545±155 * 2022 ± 102 3707 ± 163* 3149 ± 95
Zn 17.6 ± 0.7 17.7 ± 0.8 23.1 ± 1.1 22.2 ± 0.3
MT1a - - 0.66 ± 0.13 * 1.00 ± 0.05
ZnT2 - - 0.76 ± 0.07 # 1.00 ± 0.10
γ-GCSh - - 1.30 ± 0.08 † 1.00 ± 0.03
Concentration given in ppm: μg of element per g wet weight of LV. Gene
expression given in RQ = 2-ΔΔCt. normalized to HPRT expression and then to
mean of nonHG. Differences between HG and nonHG controls reported at
*P<0.05, †P<0.01.
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HG in this model led to enhanced cardiomyocyte con-
traction function at lower than in vivo stimulation fre-
quencies. These results suggest an elevated SR Ca2+ load
and release in the HG cardiomyocytes, consistent with
the greater area under the Fura-2 fluorescence ratio
transient we observed in the HG. We also found a sig-
nificantly reduced diastolic sarcomere length in the HG.
The elevated cardiomyocyte contraction function and
reduced diastolic sarcomere length in the absence of any
variation in myofilament calcium sensitivity collectively
suggest elevated systolic and diastolic intracellular Ca2+
concentrations with HG. However, we were not able to
detect an elevated diastolic Ca2+ concentration with HG.
Our measures of intracellular Ca2+ by Fura-2 suggest
that calcium regulation in the cardiomyocytes of the HG
rat were altered to contribute to an elevated SR Ca2+
load at relatively low pacing frequencies (2–4 Hz). In the
current study, we did not measure intracellular Ca2+
during exposure to extracellular Zn2+, because Fura-2 is
sensitive to both physiological Zn2+ and Ca2+ [23]. To our
knowledge, there is no other Ca2+ dye sensitive to Ca2+
with a Kd < 1 μM (which would be necessary to detect
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physiological intracellular Zn2+. Based on the response of
sarcomere dynamics, we suspect that cardiomyocyte Ca2+
load, peak systolic Ca2+ and diastolic Ca2+ concentrations
would be reduced as intracellular Zn2+ accumulated.
Cardiac elemental content and gene expression
We are aware of only two other studies of the effects
of β-islet necrosis on cardiac elemental content. LV
contents of calcium and copper were reduced in the
euthyroid rat after 6–8 wks HG due to STZ [52], and
zinc is reduced in a mouse model after 6 wks HG due
to alloxan [53]. Our findings in the euthyroid rat indi-
cate significant changes in the regulation of several
elements after HG induction by STZ; however, we
would not be able to tell if these changes are due to
the primary effects of HG or due to secondary effects
of some other syndrome accompanying HG. Interest-
ingly, gene expression levels for MT1a and ZnT2 were
reduced in the euthyroid HG rats despite the normal
levels of myocardial zinc. We speculate that HG never-
theless depresses activity of MTF-1, which is the com-
mon transcription factor to activate MT and ZnT2
[46-48]. We propose that this mechanism is reflected
in the elevated sulfur content, which suggests a higher
density of zinc-buffering sulfur-rich proteins like gluta-
thione [49] and subsequently reduced zinc availability
to signal MTF-1 activity [54].
In the hypothyroid rats, LV contents of iron and sul-
fur are elevated with 6 wks of HG and there were no
other changes in elemental contents. Therefore, there
was no zinc deficiency with HG that could account for
the higher Zn2+ sensitivity in the HG cardiomyocytes.
However, we speculate that an elevation in sulfur-rich
proteins in the HG hearts reduces the zinc available to
activate or deactivate kinases and phosphatases that
affect phosphorylation status of calcium regulatory
proteins such as RyR.
Conclusions
We demonstrate here a unique and valuable animal
model, the hypothyroid rat, which eliminated the compli-
cating factors of disparate thyroid status, myofilament
function, myosin isoform composition and post-
translational modifications due to HG or DM in euthyroid
animals. This model may prove particularly useful in fur-
ther studies of the effects of HG and DM on cardiac cellu-
lar and molecular functions.
This report provides evidence supporting zinc admin-
istration as a possible long term management regimen
for incomplete relaxation and diastolic dysfunction asso-
ciated with diabetic cardiomyopathy. Human patients
with type 2 DM demonstrate an increased mortality due
to coronary heart disease (CHD) and myocardialinfarction inversely proportional to serum zinc levels
[55]. Thus, elevation of extracellular zinc may reduce
the risks of CHD with DM, but also potentially
enhanced diastolic function in these patients most at
risk. The data presented here suggest that calcium regu-
latory mechanisms, particularly those responsible for
cytosolic Ca2+ decline in diastole, are sensitive to Zn2+
exposure and more so sensitive in the diabetic heart des-
pite normal total content of cardiac calcium and zinc.
Further investigations into the Zn2+ sensitivity of cal-
cium regulatory mechanisms responsible for relaxation,
such as Na+-Ca2+ exchanger and SERCA2a, are war-
ranted and currently underway.Competing interests
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